Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia.
Rahman S. et al, (2024), Blood
The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
DAVIES J., (2024), Nature Reviews Drug Discovery
Pioneer activity distinguishes activating from non-activating SOX2 binding sites.
Maresca M. et al, (2023), EMBO J
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia.
Crump NT. et al, (2023), Nat Commun, 14
Author Correction: Capture-C: a modular and flexible approach for high-resolution chromosome conformation capture.
Downes DJ. et al, (2023), Nat Protoc
GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells.
Turkalj S. et al, (2023), Cell Stem Cell, 30, 722 - 740.e11
Direct correction of haemoglobin E β-thalassaemia using base editors.
Badat M. et al, (2023), Nat Commun, 14
Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.
Robbe P. et al, (2022), Nat Genet, 54, 1675 - 1689
Analysis of sub-kilobase chromatin topology reveals nano-scale regulatory interactions with variable dependence on cohesin and CTCF.
Aljahani A. et al, (2022), Nat Commun, 13
Capture-C: a modular and flexible approach for high-resolution chromosome conformation capture.
Downes DJ. et al, (2022), Nat Protoc
Genotyping of Multiple Genomic Loci with Chromatin Accessibility Profiling in Single Cells Links Clonal Hierarchy with Epigenetic Variation in Acute Myeloid Leukemia
Turkalj S. et al, (2022), BLOOD, 140, 1193 - 1194
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
DOWNES D. et al, (2021), Nature Genetics
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.
Downes DJ. et al, (2021), Nat Genet, 53, 1606 - 1615
Reactivation of a developmentally silenced embryonic globin gene.
King AJ. et al, (2021), Nat Commun, 12